Correlation Between the Glasgow Prognostic Score and the Serum Cytokine Profile in Taiwanese Patients with Colorectal Cancer

1. Bray, F, Ferlay, J, Soerjomataram, I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424.
Google Scholar | Crossref | Medline2. Ma, H, Brosens, LAA, Offerhaus, GJA, et al. Pathology and genetics of hereditary colorectal cancer. Pathology 2018; 50: 49–59.
Google Scholar | Crossref | Medline3. Terzic, J, Grivennikov, S, Karin, E, et al. Inflammation and colon cancer. Gastroenterology 2010; 138: 2101–2114 e2105.
Google Scholar | Crossref | Medline4. Tuomisto, AE, Makinen, MJ, Vayrynen, JP. Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance. World J Gastroenterol 2019; 25: 4383–4404.
Google Scholar | Crossref | Medline5. Lukas, M. Inflammatory bowel disease as a risk factor for colorectal cancer. Dig Dis 2010; 28: 619–624.
Google Scholar | Crossref | Medline6. Kuo, CN, Pan, JJ, Huang, YW, et al. Association between nonsteroidal anti-inflammatory drugs and colorectal cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2018; 27: 737–745.
Google Scholar | Crossref | Medline7. McMillan, DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 2013; 39: 534–540.
Google Scholar | Crossref | Medline8. Lu, X, Guo, W, Xu, W, et al. Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients. Cancer Manag Res 2019; 11: 229–249.
Google Scholar | Crossref | Medline9. Goyal, A, Terry, MB, Jin, Z, et al. C-reactive protein and colorectal cancer mortality in U.S. adults. Cancer Epidemiol Biomarkers Prev 2014; 23: 1609–1618.
Google Scholar | Crossref | Medline10. Nozoe, T, Mori, E, Takahashi, I, et al. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surg Today 2008; 38: 597–602.
Google Scholar | Crossref | Medline11. Kim, S, McClave, SA, Martindale, RG, et al. Hypoalbuminemia and clinical outcomes: what is the mechanism behind the relationship? Am Surg 2017; 83: 1220–1227.
Google Scholar | SAGE Journals12. Lai, CC, You, JF, Yeh, CY, et al. Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis 2011; 26: 473–481.
Google Scholar | Crossref | Medline13. Gunawardene, A, Dennett, E, Larsen, P. Prognostic value of multiple cytokine analysis in colorectal cancer: a systematic review. J Gastrointest Oncol 2019; 10: 134–143.
Google Scholar | Crossref | Medline14. Chen, XL, Chen, ZQ, Zhu, SL, et al. Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis. BMC Cancer 2017; 17: 240.
Google Scholar | Crossref | Medline15. Abtahi, S, Davani, F, Mojtahedi, Z, et al. Dual association of serum interleukin-10 levels with colorectal cancer. J Cancer Res Ther 2017; 13: 252–256.
Google Scholar | Crossref | Medline16. Langrish, CL, Chen, Y, Blumenschein, WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233–240.
Google Scholar | Crossref | Medline | ISI17. Yan, G, Liu, T, Yin, L, et al. Levels of peripheral Th17 cells and serum Th17-related cytokines in patients with colorectal cancer: a meta-analysis. Cell Mol Biol (Noisy-le-grand) 2018; 64: 94–102.
Google Scholar | Crossref | Medline18. Vayrynen, JP, Kantola, T, Vayrynen, SA, et al. The relationships between serum cytokine levels and tumor infiltrating immune cells and their clinical significance in colorectal cancer. Int J Cancer 2016; 139: 112–121.
Google Scholar | Crossref | Medline19. Chen, ZY, He, WZ, Peng, LX, et al. A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients. Int J Cancer 2015; 136: 584–592.
Google Scholar | Medline20. Chen, ZY, Raghav, K, Lieu, CH, et al. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. Br J Cancer 2015; 112: 1088–1097.
Google Scholar | Crossref | Medline21. Read, JA, Choy, ST, Beale, PJ, et al. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer 2006; 55: 78–85.
Google Scholar | Crossref | Medline | ISI22. World Health Organization . Definition of an older or elderly person, www.who.int/healthinfo/survey/ageingdefnolder/en/ (2016, accessed 26 July 2016).
Google Scholar23. National Heart Lung, and Blood Institute . Assessing your weight and health risk, www.nhlbi.nih.gov/health/educational/lose_wt/risk.htm (2012, accessed 2 April 2012).
Google Scholar24. Bohlius, J, Weingart, O, Trelle, S, et al. Cancer-related anemia and recombinant human erythropoietin–an updated overview. Nat Clin Pract Oncol 2006; 3: 152–164.
Google Scholar | Crossref | Medline25. Araki, K, Ito, Y, Fukada, I, et al. Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel. BMC Cancer 2018; 18: 982.
Google Scholar | Crossref | Medline26. Pan, YP, Chang, PH, Fan, CW, et al. Relationship between pre-treatment nutritional status, serum glutamine, arginine levels and clinicopathological features in Taiwan colorectal cancer patients. Asia Pac J Clin Nutr 2015; 24: 598–604.
Google Scholar | Medline27. Ghuman, S, Van Hemelrijck, M, Garmo, H, et al. Serum inflammatory markers and colorectal cancer risk and survival. Br J Cancer 2017; 116: 1358–1365.
Google Scholar | Crossref | Medline28. Park, JW, Chang, HJ, Yeo, HY, et al. The relationships between systemic cytokine profiles and inflammatory markers in colorectal cancer and the prognostic significance of these parameters. Br J Cancer 2020; 123: 610–618.
Google Scholar | Crossref | Medline29. Vayrynen, JP, Tuomisto, A, Klintrup, K, et al. Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer 2013; 109: 1839–1847.
Google Scholar | Crossref | Medline30. Kim, IH, Lee, JE, Yang, JH, et al. Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response. Asia Pac J Clin Oncol 2018; 14: 239–246.
Google Scholar | Crossref | Medline31. Choi, KW, Hong, SW, Chang, YG, et al. Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients. Ann Surg Treat Res 2014; 86: 309–313.
Google Scholar | Crossref | Medline32. Miki, C, Konishi, N, Ojima, E, et al. C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci 2004; 49: 970–976.
Google Scholar | Crossref | Medline | ISI33. Mold, C, Rodriguez, W, Rodic-Polic, B, et al. C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R. J Immunol 2002; 169: 7019–7025.
Google Scholar | Crossref | Medline | ISI34. Szalai, AJ, Nataf, S, Hu, XZ, et al. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J Immunol 2002; 168: 5792–5797.
Google Scholar | Crossref | Medline | ISI35. Brenner, DA, Buck, M, Feitelberg, SP, et al. Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. J Clin Investig 1990; 85: 248–255.
Google Scholar | Crossref | Medline36. Quispe, EA, Li, XM, Yi, H. Comparison and relationship of thyroid hormones, IL-6, IL-10 and albumin as mortality predictors in case-mix critically ill patients. Cytokine 2016; 81: 94–100.
Google Scholar | Crossref | Medline37. Sarris, AH, Kliche, KO, Pethambaram, P, et al. Interleukin-10 levels are often elevated in serum of adults with Hodgkin’s disease and are associated with inferior failure-free survival. Ann Oncol 1999; 10: 433–440.
Google Scholar | Crossref | Medline | ISI38. Fearon, KC, Glass, DJ, Guttridge, DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 2012; 16: 153–166.
Google Scholar | Crossref | Medline | ISI39. Porporato, PE. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis 2016; 5: e200.
Google Scholar | Crossref | Medline | ISI40. Shibata, M, Fukahori, M, Kasamatsu, E, et al. A retrospective cohort study to investigate the incidence of cachexia during chemotherapy in patients with colorectal cancer. Adv Ther 2020; 37: 5010–5022.
Google Scholar | Crossref | Medline41. Dewys, WD, Begg, C, Lavin, PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69: 491–497.
Google Scholar | Crossref | Medline | ISI42. Vayrynen, JP, Vayrynen, SA, Sirnio, P, et al. Platelet count, aspirin use, and characteristics of host inflammatory responses in colorectal cancer. J Translat Med 2019; 17: 199.
Google Scholar | Crossref | Medline43. Sirnio, P, Tuomisto, A, Tervahartiala, T, et al. High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer. Br J Cancer 2018; 119: 213–219.
Google Scholar | Crossref | Medline44. Vayrynen, JP, Tuomisto, A, Vayrynen, SA, et al. Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survival. Sci Rep 2018; 8: 1126.
Google Scholar | Crossref | Medline45. Sharma, R, Zucknick, M, London, R, et al. Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer. Clin Colorectal Cancer 2008; 7: 331–337.
Google Scholar | Crossref | Medline46. Chang, PH, Pan, YP, Fan, CW, et al. Pretreatment serum interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha levels predict the progression of colorectal cancer. Cancer Med 2016; 5: 426–433.
Google Scholar | Crossref | Medline47. Jessup, JM, Laguinge, L, Lin, S, et al. Carcinoembryonic antigen induction of IL-10 and IL-6 inhibits hepatic ischemic/reperfusion injury to colorectal carcinoma cells. Int J Cancer 2004; 111: 332–337.
Google Scholar | Crossref | Medline48. Roselli, M, Guadagni, F, Martini, F, et al. Association between serum carcinoembryonic antigen and endothelial cell adhesion molecules in colorectal cancer. Oncology 2003; 65: 132–138.
Google Scholar | Crossref | Medline49. Lippitz, BE, Harris, RA. Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis. Oncoimmunology 2016; 11: e1093722.
Google Scholar |

留言 (0)

沒有登入
gif